📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Natera

1.1 - Company Overview

Natera Logo

Natera

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cell-free DNA testing solutions for oncology, women's health, and organ health, including Signatera, a personalized molecular residual disease test using ctDNA to detect and quantify cancer presence and aid early recurrence detection and treatment optimization; Panorama non-invasive prenatal screening; Prospera donor-derived cell-free DNA test for transplant rejection assessment; and Renasight genetic testing for chronic kidney disease.

Products and services

  • Panorama: A non-invasive NIPT that screens for genetic conditions in a fetus using cell-free DNA from the mother’s blood
  • Prospera: A donor-derived cell-free DNA test for assessing organ transplant rejection, delivering insights into the health of transplanted organs
  • Signatera: A personalized ctDNA molecular residual disease test that detects and quantifies cancer presence, aiding early recurrence detection and treatment optimization

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Natera

Elucigene Logo

Elucigene

HQ: United Kingdom Website
  • Description: Provider of clinical diagnostic assays and product realisation services, offering kits for cystic fibrosis (CFTR mutations), rapid aneuploidy analysis (QF-PCR for trisomies 21, 18, 13 and sex chromosome aneuploidies), reproductive health (recurrent miscarriage, male infertility, Y-microdeletion), and genetic disease diagnosis (thrombophilia, alpha-1-antitrypsin). Services include assay development, validation, manufacturing, regulatory strategy, and commercial sale and distribution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elucigene company profile →
Focus Diagnostics Logo

Focus Diagnostics

HQ: United States Website
  • Description: Provider of molecular and immunodiagnostic products and platforms for hospitals and commercial laboratories worldwide. Offers Simplexa molecular chemistries, HerpeSelect type-specific serology, and DxSelect IFA/ELISA kits for diseases such as West Nile Virus and Rickettsia, plus Luminex LTG, LIAISON PLEX multiplexing (including Respiratory Flex Assay), and LIAISON XL/XS automated CLIA assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Focus Diagnostics company profile →
Blueprint Genetics Logo

Blueprint Genetics

HQ: Finland Website
  • Description: Provider of clinical genetic testing and diagnostics for rare diseases using NGS, serving hospitals and research groups. Offerings include Whole Exome Sequencing, panel-based NGS, variant interpretation with clinical statements per ACMG guidelines, and a Quality Management System with analytic validation and quality control.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Blueprint Genetics company profile →
Biological Dynamics Logo

Biological Dynamics

HQ: United States Website
  • Description: Provider of next-gen liquid biopsy solutions using a true multiomics approach to detect early cancer in blood; offers the ExoVerita Pro system and platform for automated exosome isolation via alternating current electrokinetics; develops exosome- and proteomics-based diagnostic assays; leads ExoLuminate pancreatic cancer study; and runs a Technology Access Program offering partners access to Biological Dynamics' system for diagnostic solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biological Dynamics company profile →
Athena Diagnostics Logo

Athena Diagnostics

HQ: United States Website
  • Description: Provider of diagnostic testing for neurological disorders, offering genetic tests for conditions such as Parkinson’s, Spinocerebellar Ataxia Type 3, Myotonic Dystrophy, Alzheimer’s, and Spinal Muscular Atrophy; the NAbFeron (IFNB-1) neutralizing antibody test for Multiple Sclerosis; informed consent resources; requisition forms; shipping kits; and the IntelliTest Manager web portal for test information management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Athena Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Natera

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Natera

2.2 - Growth funds investing in similar companies to Natera

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Natera

4.2 - Public trading comparable groups for Natera

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Natera

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Natera

What does Natera do?

Natera is a provider of cell-free DNA testing solutions for oncology, women's health, and organ health, including Signatera, a personalized molecular residual disease test using ctDNA to detect and quantify cancer presence and aid early recurrence detection and treatment optimization; Panorama non-invasive prenatal screening; Prospera donor-derived cell-free DNA test for transplant rejection assessment; and Renasight genetic testing for chronic kidney disease.

Who are Natera's competitors?

Natera's competitors and similar companies include Elucigene, Focus Diagnostics, Blueprint Genetics, Biological Dynamics, and Athena Diagnostics.

Where is Natera headquartered?

Natera is headquartered in United States.

How many employees does Natera have?

Natera has 1,000 employees 🔒.

When was Natera founded?

Natera was founded in 2010 🔒.

What sector and industry vertical is Natera in?

Natera is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Natera

Who are the top strategic acquirers in Natera's sector and industry

Top strategic M&A buyers and acquirers in Natera's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Natera?

Top strategic M&A buyers groups and sectors for Natera include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Natera's sector and industry vertical

Which are the top PE firms investing in Natera's sector and industry vertical?

Top PE firms investing in Natera's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Natera's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Natera's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Natera's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Natera include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Natera's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Natera?

The key public trading comparables and valuation benchmarks for Natera include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Natera for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Natera with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Natera's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Natera with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Natera's' sector and industry vertical?

Access recent funding rounds and capital raises in Natera's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Natera